These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10590487)

  • 1. Secondary prevention of sudden death.
    Cappato R; Kuck KH
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():39-44. PubMed ID: 10590487
    [No Abstract]   [Full Text] [Related]  

  • 2. Ventricular tachycardia and ventricular fibrillation.
    Srivathsan K; Ng DW; Mookadam F
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating AVID, CASH, CIDS, CABG-patch and MADIT: are they concordant?
    Böcker D; Breithardt G
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():103-8. PubMed ID: 10590496
    [No Abstract]   [Full Text] [Related]  

  • 4. Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest?
    Zipes DP
    Circulation; 1995 Apr; 91(8):2115-7. PubMed ID: 7697837
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary and secondary prevention of sudden cardiac death].
    Janion M; Sadowski M; Sielski J; Janion-Sadowska A
    Pol Arch Med Wewn; 2006 Jan; 115(1):65-72. PubMed ID: 17278788
    [No Abstract]   [Full Text] [Related]  

  • 6. [ESC guidelines 2015 for ventricular arrhythmias and prevention of sudden cardiac death. What is new?].
    Fink T; Kuck KH; Metzner A;
    Herz; 2015 Dec; 40(8):1034-42. PubMed ID: 26626552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ventricular arrhythmias : What has been confirmed in therapy?].
    Duncker D; Bauersachs J; Veltmann C
    Internist (Berl); 2017 Dec; 58(12):1272-1280. PubMed ID: 29071387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment approaches for patients with sustained VT/VF.
    Mitchell LB; Roy D
    Can J Cardiol; 2000 Jun; 16 Suppl C():23C-5C. PubMed ID: 10887274
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
    Prystowsky EN
    Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R
    Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attributes of a prophylactic implantable cardioverter defibrillator: how close are we?
    Hauser RG
    Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 2):582-5. PubMed ID: 7681961
    [No Abstract]   [Full Text] [Related]  

  • 13. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C; Yan GX; Kocovic D; Kowey PR
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
    Böcker D; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study).
    Kuck KH; Tilz RR; Deneke T; Hoffmann BA; Ventura R; Hansen PS; Zarse M; Hohnloser SH; Kautzner J; Willems S;
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic implications and strategies to avoid ICD shocks].
    Horlbeck FW; Nickenig G; Schwab JO
    Dtsch Med Wochenschr; 2014 Sep; 139(39):1932-6. PubMed ID: 25225862
    [No Abstract]   [Full Text] [Related]  

  • 17. Implantable defibrillators and antiarrhythmic drugs in patients at risk for lethal arrhythmias.
    Zivin A; Bardy GH
    Am J Cardiol; 1999 Nov; 84(9A):63R-68R. PubMed ID: 10568662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators: not the ultimate gold standard for gauging therapy of VT/fibrillation.
    Singh BN
    Am J Cardiol; 1994 Jun; 73(16):1211-3. PubMed ID: 8203341
    [No Abstract]   [Full Text] [Related]  

  • 20. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
    Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.